The AXIOM Sensis system is intended for use as a diagnostic and administrative tool supporting hemodynamic cardiac catheterizations and/or intracardiac electrophysiology studies. The system is equipped by modules, enabling various configurations ranging from a stand-alone acquisition unit with limited administrative functionality to multiunit installations with a common database and satellite workstations accessing the administrative tools.
The AXIOM Sensis system has functions for:

External communication via the DICOM interface by using Siemens Medical Platform 1. syngo ™and AXIOM Sensis VC00A DICOM Conformance Statement
External Communication via the HL7 interface by using AXIOM Sensis Interface description 2: · HL7 Interface.
1. Local communication by using the Siemens HICOR interface
Local communication by using the Siemens AXIOM Artis FC/BC interface 4.
Local communication with Medtronic Model 4803, Atakr® II RF Power Generator, Boston ર. Scientific EP Technologies EPT-100 TC. and Stockert EP-Shuttle Ablator devices

Device Description

AXIOM Sensis is a multi-channel computer-based stationary system for the measurement, display, and printout of biophysiological events. Hemodynamic and electrophysiological signals such as intracardiac pressure, ECG signals, and intracardiac electrograms (ICEG) are measured and displayed by the system. AXIOM Sensis software provides the ability to monitor and assess invasive blood pressure, ECG signals, and optionally intracardiac electrograms (ICEG). With the AXIOM Sensis system the user can perform a number of calculations based on the input signals and other hemodynamic parameter values entered by the user.

AI/ML Overview

This 510(k) summary describes a diagnostic and administrative tool for hemodynamic cardiac catheterizations and/or intracardiac electrophysiology studies. The submission focuses on substantial equivalence to predicate devices rather than presenting a performance study with detailed acceptance criteria and results. Therefore, many of the requested sections regarding acceptance criteria, study details, and ground truth establishment cannot be fully populated from the provided text.

Here is the information that can be extracted or inferred:

1. A table of acceptance criteria and the reported device performance

The provided document does not explicitly state acceptance criteria or present a performance table as would be typical for a new standalone device. Instead, the focus is entirely on demonstrating substantial equivalence to existing legally marketed predicate devices. The implied "acceptance criterion" is that the device's technological characteristics, intended use, and safety/effectiveness are comparable to the identified predicate devices.

The "reported device performance" is essentially the statement of substantial equivalence itself, based on:

Technological Characteristics: "AXIOM Sensis goes one-step beyond the currently available systems to create modular units with component commonality, streamlined user interface and use, and performance and reliability improvement." This is a general claim, not specific performance metrics.
Communication Interfaces: Support for DICOM, HL7, Siemens HICOR, Siemens AXIOM Artis, and communication with specific ablation devices (Medtronic Model 4803 Atake® II RF Power Generator, Boston Scientific EP Technologies EPT-100 TC, and Stockert EP-Shuttle ablation devices).
Platform: Based on the Syngo platform, which itself received 510(k) clearance (K010938).
Safety/Effectiveness: Reliance on "recognized and established industry practice" and "all equipment is subject to final performance testing," with instructions for use to allow trained healthcare professionals to operate it safely and efficaciously.

Acceptance Criterion (Implied by Substantial Equivalence)	Reported Device Performance (from document)
Substantially equivalent to predicate devices for intended use	"AXIOM Sensis system is substantially equivalent to the following legally market devices: GE PRUCKA CARDIOLAB® 7000 (K993414), Siemens CATHCOR LX Desktop (K002137), Siemens EPCOR option (K930786), Nonin Neonatal/Adult Vital Sign Monitor (SpO2) (K982776), SunTech Oscar II BP Monitor (NIBP) (K003004), SC9000 Infinity Monitor (HR & CO) (K980882)."
Technological characteristics comparable to predicates	"AXIOM Sensis goes one-step beyond the currently available systems to create modular units with component commonality, streamlined user interface and use, and performance and reliability improvement." Also mentions support for various communication interfaces (DICOM, HL7, HICOR, AXIOM Artis, and specific ablation devices).
Safety and Efficacy for intended use	Relies on "recognized and established industry practice" for minimizing hazards and states that "all equipment is subject to final performance testing." Instructions are provided for safe operation by trained professionals.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Not applicable. The submission describes a device based on substantial equivalence and does not detail a study involving a test set of data or human performance evaluation. There is no mention of data provenance.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable. As no test set for clinical performance evaluation is described, there's no mention of experts establishing ground truth.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. No test set requiring adjudication is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. The device is a diagnostic and administrative tool for hemodynamic and electrophysiology studies, not an AI-assisted diagnostic tool for interpretation by human readers. No MRMC study is described.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

This refers to a standalone performance study. The document confirms that "all equipment is subject to final performance testing." However, specific details about such testing (e.g., protocols, acceptance criteria, results for individual measurements) are not provided in this 510(k) summary. The submission relies on the substantial equivalence to predicate devices, which generally means that if the core functionalities and measurements are within acceptable ranges (implicitly, similar to the predicates), then it is deemed safe and effective.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

Not applicable in the context of a clinical performance study. For the measurements the device performs (e.g., invasive blood pressure, ECG signals, intracardiac electrograms), the "ground truth" would be established by the physical sensing and measurement principles, calibrated against known standards, similar to the predicate devices.

8. The sample size for the training set

Not applicable. This device is not described as involving machine learning or AI that would require a "training set" in the conventional sense.

9. How the ground truth for the training set was established

Not applicable, as no training set is described.

Summary

{0}------------------------------------------------

510(K) SUMMARY

Submitted by: Siemens Medical Solutions USA, Inc. 186 Wood Avenue South Iselin, NJ 08830

DEC 0 3 2002

This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR § 807.92.

1.	Contact Person
	Sandra Robinson
	Technical Specialist
	Phone (732) 321-3243	Fax: (732) 321-4841

2. Device Name and Classification

Trade Name: Internal name of R&D: Classification name: Classification Panel Classification Number Classification class

AXIOM Sensis NEWCOR Programmable diagnostic computer 21 CFR § 870.1425 DQK II

3. Intended Use

4. Substantial Equivalence

AXIOM Sensis system is substantially equivalent to the following legally market devices:

GE PRUCKA CARDIOLAB® 7000	K993414, cleared on April 7, 2000
Siemens CATHCOR LX Desktop	K002137, cleared on Oct 5, 2000
Siemens EPCOR option	K930786, cleared on Sept 26, 1996
Nonin Neonatal/Adult Vital Sign Monitor (SpO2)	K982776, cleared on Aug 9, 1998
SunTech Oscar II BP Monitor (NIBP)	K003004, cleared on Oct 25, 2000
SC9000 Infinity Monitor (HR & CO)	K980882, cleared on June 5, 1998

Information that substantiates this claim of equivalence is provided throughout this 510(k) submission and specific equivalence information is provided in section M.

ડ. Device Description

{1}------------------------------------------------

Summary of Technological Characteristics of the Principal Device as Compared with the 6. Predicate Device

AXIOM Sensis goes one-step beyond the currently available systems to create modular units with component commonality, streamlined user interface and use, and performance and reliability improvement.

Technological Characteristics:

The Axiom Sensis described supports a subset of DICOM and HL 7 communication interfaces, communication with Siemens X-ray systems via HICOR and Axiom Artis communication protocols, and communication of parameter data from Medtronic Model 4803 Atake® II RF Power Generator, Boston Scientific EP Technologies EPT-100 TC and Stockert EP-Shuttle ablation devices.

AXIOM Sensis is based on the Syngo platform, which received FDA 510(k) clearance K010938 on June 25, 2001.

7. General Safety and Effectiveness Concerns

Instructions for use are included within the device labelling and the information provided will enable the trained healthcare professional to operate the device in a safe and efficacious manner. Furthermore the operators are health care professionals familiar with and responsible for the examinations to be performed. To minimize electrical, mechanical and radiation hazards, Siemens adheres to recognized and established industry practice, and all equipment is subject to final performance testing.

8. Substantial Equivalence

In the opinion of Siemens Medical Systems, Inc., the hardware and software documentation and the substantial equivalence comparison matrix proves that the AXIOM Sensis Electrophysiological and Hemodynamic Recording System is substantially equivalent to the Siemens Medical Systems, Inc. predicate Cathcor LX Desktop System, with EPCOR option and the General Electric Inc. Prucka Cardiolab 7000 system.

AXIOM Sensis is substantial equivalent on parameter level with Nonin Neonatal/Adult Vital Sign Monitor (SpO2), SunTech Oscar II BP Monitor (NIBP) and Siemens SC9000 Infinity Monitor (HR & CO).

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image is blurry and difficult to make out any details. It appears to show some text, but the text is not legible. It is not possible to provide a more detailed description of the image.

DEC 0 3 2002

od and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Siemens Medical Systems, Inc. c/o Ms. Kathleen Rutherford Manager, Regulatory Submissions 186 Wood Avenue South Iselin, NJ 08830

Re: K020440 Trade Name: AXIOM Sensis Regulation Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II (two) Product Code: DQK Dated: Undated Received: September 5, 2002

Dear Ms. Rutherford:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition. FI > Part publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Ms. Kathleen Rutherford

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97), Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

Kaitlin

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Spetion 11

510(k) Number (if known):

Device Name: AXIOM Sensis

Indications For Use: ·

The AXIOM Sensis system is intended to be used as a diagnostic and administrative tool supporting hemodynamic cardiac catheterizations and/or intracardiac electrophysiology studies. The system is equipped by modules, enabling various configurations ranging from a stand-alone acquisition unit with limited administrative functionality to multiunit installations with a common database and satellite workstations accessing the data using the administrative tools.

The AXIOM Sensis system has functions for:

External communication via the DICOM interface by using Siemens Medical Platform 1. syngo ™and AXIOM Sensis VC00A DICOM Conformance Statement
External Communication via the HL7 interface by using AXIOM Sensis Interface description 2: · HL7 Interface.
1. Local communication by using the Siemens HICOR interface
Local communication by using the Siemens AXIOM Artis FC/BC interface 4.
Local communication with Medtronic Model 4803, Atakr® II RF Power Generator, Boston ર. Scientific EP Technologies EPT-100 TC. and Stockert EP-Shuttle Ablator devices

The device is intended to be used on either or both of the following populations:

Adult and pediatric populations requiring intracardiac electrophysiology examinations, typically 1 . when the patient is suffering from cardiac arrhythmias.
Adult and pediations requiring intracardiac hemodynamic examinations, typically when 2. the patient has a heart disease resulting in insufficient hemodynamic functionality.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801. OR

Over-The-Counter Use_

Division of Cardiovascular & Respiratory Devices
510(k) Number

510(K) for Siemens AXIOM Sensis Siemens Medical Solutions USA, Inc. Section H, Page I of 1

Regulation Number and Section

§ 870.1425 Programmable diagnostic computer.

(a)
Identification. A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.(b)
Classification. Class II (performance standards).